E-mail

E-mail a Wiley Online Library Link

Xiao-Bing Wang, Xing-Ran Jiang, Xi-Ying Yu, Lin Wang, Shun He, Fei-Yue Feng, Li-Ping Guo, Wei Jiang and Shih-Hsin Lu Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy Cancer Science 105

Article first published online: 2 JAN 2014 | DOI: 10.1111/cas.12331

Thumbnail image of graphical abstract

Serum MIC1 may serve as a diagnostic marker and an independent prognostic factor for ESCC. Additionally,monitoring of serum MIC1 after surgery is useful in evaluation of early recurrence. Notably, this study highlights that the over-expression of MIC1 was associated with lymph node metastasis and MIC1 can act as a therapeutic target for antibody-based therapy in the treatment of ESCC.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH